Articles & Press Releases

“What do you mean your partner? Does that mean a man?” These were among the questions one of my mentors asked me when we were discussing my list of pros and cons regarding the vascular surgery residency training programs to which I would apply. “Yes, my partner is a man.” The expected “oh…” was a reply I heard going to research meetings and throughout the residency interview trail. Unclear was whether this “oh” was one of disappointment, a nervous response, or concern if I would “fit” in vascular surgery. This “oh” haunts me because, in one short utterance, all of my accomplishments can be easily stripped away.

This year, the two major meetings of the Society for Vascular Surgery (SVS) that involve the presentation of scientific research are being housed in one tent. The Vascular Research Initiatives Conference (VRIC), typically held in May and geared to translational research, will be held over two sessions Thursday and Friday at the 2021 Vascular Annual Meeting (VAM). More than 25 abstracts will be presented in four sessions covering arterial remodeling and discovery science for venous disease; vascular regeneration, stem cells and wound healing; atherosclerosis and the role of the immune system; and aortopathies and novel vascular devices.

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.

The United States has been living through some charged times recently. Our profession is not immune to these conflagrations. In recent times, minority members of the diverse specialty of vascular surgery have seen people who look like them come under attack. And there are politicians and other actors who make it their mission to try to divide us. Against this backdrop, I will relate a personal journey of confronting discrimination and, ultimately, of hope and acceptance.

Kathryn Bowser, MD, a member of the Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee, talks to Justin Michel, 29, who identifies as a non-binary trans masculine person, about the patient experience navigating medical care as an individual of minority sexual identity.

Organizers stress that the best way to experience the 2021 Vascular Annual Meeting (VAM) is in-person, surrounded by friends and colleagues, participating in small-group sessions and seeing all the devices and information available in the Exhibit Hall. All the abstract-based plenary sessions will be live-streamed, as will four international events, specialty lectures and the two presidential addresses. A total of 15 Continuing Medical Education (CME) credits can be earned from among the streamed sessions.

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

A single-center retrospective study suggests avoiding Propofol or intra-procedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol is the most commonly used parenteral anesthetic agent in the United States, extensively used for minor and outpatient surgical procedures because of its rapid onset and reversal of action, and in intensive care units for maintenance of coma.

Medtronic is making updated patient management recommendations related to its voluntary recall of the Valiant Navion™ Thoracic Stent Graft on February 17th, which included the patient recommendation for physicians to follow best clinical practice and make best efforts to evaluate patients with at

The Vascular Annual Meeting (VAM) is more anticipated than ever after the annus horribilis of 2020 and the pared-back, digital VAM alternative that was SVS ONLINE. While organizers have previously relayed the changes made for this year’s meeting, Program Committee co-chair Matthew Eagleton, MD, took the opportunity to once again emphasize the significant changes to its structure for 2021, with educational programming presented across all four days— Wednesday through Saturday.

The recent decision from the National Heart, Lung, and Blood Institute (NHLBI) to reduce the dedicated research effort from 75 to 50% for K awards is a landmark change and will have a tremendous impact on vascular surgeons.The decision affects the June 2021 submission date and applies to vascular, cardiothoracic and trauma surgeons, as well as interventional.

Register today for the remaining Society for Vascular Surgery (SVS) "Meet the Experts" webinars, including "Redo Carotoid Revascularization,” to be held May 20. These webinars are free for SVS members and residents/trainees. Nonmembers will pay $35 for each webinar. They are limited to 100 participants to permit an intimate feel and provide for faculty-audience conversations.

The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching are developing a first-of-its-kind coaching program that strengthens wellness support for vascular surgeons. Studies show they—along with physicians across specialties—are experiencing an increase in burnout, anxiety, depression and suicidal ideation.

With social media having such a prevalent presence today, it continues to play a significant role in connecting surgeons, prospective trainees and medical students throughout the vascular community. The Society for Vascular Surgery (SVS) Social Media Committee has launched its newest initiative to keep members connected, the new monthly #SVSTweetChat series. Each month, expert panelists will share career advice, hot topics of debate, and innovations in the vascular field with the Twitter community.

Voting runs from May 17 to 24 on proposed bylaws amendments and for the position of vice president of the Society for Vascular Surgery. Immediately preceding the opening of voting, SVS leaders will host a Town Hall from 6 to 8 p.m. Central Daylight Time, “Leading the Way in 2021: An Evening with the Appointments and Nominating Committees.” President Ronald L. Dalman, MD, will facilitate the Town Hall.